A motor function measurement scale for neuromuscular diseases - Description and validation study;La mesure de fonction motrice, outil d'évaluation clinique des maladies neuromusculaires. Étude de validation

Revue Neurologique

Volumn 162, Issue 4, 2006, Pages 485-493

  Berard C ^a   Payan, C ^b   Fermanian, J ^c   Girardot, F ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Clinical trials; Metrology; Motor function; Neuromuscular disease; Scale; Validation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MUSCULAR DYSTROPHY; MYOPATHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROPATHY; PHYSICIAN; PHYSIOTHERAPIST; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SPINAL MUSCULAR ATROPHY; STATISTICAL SIGNIFICANCE; VALIDATION STUDY; VISUAL ANALOG SCALE;

EID: 33645769504     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75039-1     Document Type: Article

References (19)

1. ABRESCH RT, SEYDEN NK, WINEINGER MA. (1998). Quality of life. Issues for persons with neuromuscular diseases. Phys Med Rehabil Clin N Am, 9: 233-248.
2. BERARD C, PAYAN C, HODGKINSON I et al. (2001). Motor function measure for neuromuscular diseases. Validation of the first version scale. Neuromuscul Disord, 11: 361.
3. BERARD C, PAYAN C, HODGKINSON I, FERMANIAN J and the MFM collaborative study group (2005). A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromuscul Disord, 15: 463-470.
4. BROOKE MH, GRIGGS RC, MENDELL JR, FENICHEL GM, SHUMATE JB. (1981). Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve, 4: 186-197.
5. BROOKE MH, FENICHEL GM, GRIGGS RC et al. (1983). Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve, 6: 91-103.
6. FRIES JF, SPITZ P, YOUNG D. (1982). The dimensions of health outcomes: the Health Assessment Questionnaire, Disability and Pain scales. J. Rhumatol, 9: 789-793.
7. GUILLEMIN F, BRIANCON S, POUREL J. (1991). Mesure de la capacité fonctionnelle dans la Polyarthrite Rhumatoide : Adaptation française du Health Assessment Qestionnaire (HAQ). Rev Rhum, 58: 459-465.
8. GUINVARC'H S. (2001). Évaluation neuropsychologique et psychologique, évaluation des capacités motrices, de l'indépendance fonctionnelle, évaluation de la qualité de vie. Ann Med Phys Readap, 1: 85-104.
9. GUINVARCH S, BERARD C, CALMELS P. (2003). Affections neuromusculaires. In: Guide des outils de mesure et d'évaluation en médecine physique et de réadaptation. F. Bethoux, P. Calmels. Ed Frison-Roche, Paris, pp. 269-283.
10. IANNACCONE ST, BROWNE RH, SAMAHA FJ, BUNCHER CR, DCN/SMA GROUP. (1994). Prospective study of spinal muscular atrophy before age 6 years. Pediatr Neurol, 9: 187-193.
11. JEBSEN RH, TAYLOR N, TRIESCHMANN RB, TROTTER MJ, HOWARD LA. (1969). An objective and standardized test of hand function. Arch Phys Med Rehabil, 12: 17-19.
12. MAIN M, KAIRON H, MERCURI E, MUNTONI F. (2003). The hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and motor progress in children with limited ambulation. Europ J Paed Neurol, 7: 155-159.
13. POUCHOT J, RUPERTO N, LEMELLE I et al (2001). Clin Exp. Rheumatol, 19: 60-65.
14. RUSSELL D, ROSENBAUM P, CADMAN D, GOWLAND C, HARDY S, JARVIS S. (1989). The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol, 31: 341-352.
15. SCOTT OM, HYDE SA, GODDARD C, DUBOWITZ V. (1982). Quantification of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve, 5: 291-301.
16. STEFFENSEN BF, LYAGER S, WERGE B, RAHBEK J, MATTSSON E. (2002). Physical capacity in non-ambulatory people with Duchenne muscular dystrophy and spinal muscular atrophy. A longitudinal study. Dev Med Child Neurol, 44: 623-632.
17. VIGNOS PJ, SPENCER GE, ARCHIBALD KC. (1963). Management of progressive muscular dystrophy of childhood. JAMA, 184: 89-96.
18. e ed, Livingstone.
19. ZUPAN A. (1996). Assessment of the functional abilities of the upper limbs in patients with neuromuscular diseases. Disabil Rehabil, 18: 69-75.